Drug Database
Back to search

Netherlands· NL-aa0f5b4ea019

COPALIA HCT 10 mg/160 mg/12,5 mg filmomhulde tabletten

A valsartan, amlodipine and hydrochlorothiazide product containing amlodipinebesilaat + hydrochloorthiazide + valsartan, registered in Netherlands by Novartis Europharm Limited. The same ATC class is registered in 12 of our 19 countries.

ATC C09DX01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedCOPALIA HCT 10 mg/160 mg/12,5 mg film…ATCC09DX01REGISTER NO.NL-aa0f5b4ea019PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about amlodipinebesilaat + hydrochloorthiazide + valsartanAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Valsartan, amlodipine and hydrochlorothiazide is registered in 12 of 19 countries.

Countries holding a registration under ATC C09DX01 (valsartan, amlodipine and hydrochlorothiazide), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose
Search valsartan, amlodipine and hydrochlorothiazide products by name

Valsartan, amlodipine and hydrochlorothiazide · ATC C09DX01

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
AMLODIPINEBESILAAT + HYDROCHLOORTHIAZIDE + VALSARTAN
Manufacturer
Novartis Europharm Limited
Country
Netherlands (NL)
ATC code
C09DX01
ATC class
Valsartan, amlodipine and hydrochlorothiazide
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/09/575

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

48 interactions on record for valsartan, amlodipine and hydrochlorothiazide.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check valsartan, amlodipine and hydrochlorothiazide against other medicinesHow interaction checks work

Valsartan, amlodipine and hydrochlorothiazide · interactions on record

48 records

48 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same class

Other records under C09DX01

Valsartan, amlodipine and hydrochlorothiazide, as other registers publish it.

All valsartan, amlodipine and hydrochlorothiazide products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d4445639-c2c0-4337-8d49-387c28dbd745
GET /v1/drugs/d4445639-c2c0-4337-8d49-387c28dbd745?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/copalia-hct-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Valsartan, amlodipine and hydrochlorothiazide",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp105216",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSPOVIDON (E 1202)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ROOD  (E 172)",
    "MACROGOL 4000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "SILICIUMDIOXIDE (E 551)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "AMLODIPINEBESILAAT",
    "HYDROCHLOORTHIAZIDE",
    "VALSARTAN"
  ],
  "leaflet_url": null,
  "authorised_at": "2009/11/04",
  "procedure_number": "EMEA/H/C/001159",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/09/575",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about valsartan, amlodipine and hydrochlorothiazide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console